Case Study · IBM ELA Optimisation

IBM ELA Review and Optimisation for a French Global Professional Services Company €4.7M Annual Savings. 25% ELA Cost Reduction. 42% Product Portfolio Reduction.

A global professional services company headquartered in France engaged Redress Compliance to review its IBM Enterprise License Agreement ahead of renewal. The engagement uncovered compliance gaps, identified €4.7 million in annual savings, and secured a 25% reduction in total ELA cost through strategic negotiation.

€4.7MAnnual Savings
25%ELA Cost Reduction
50+Countries Assessed
100%Compliance Achieved
Part of our IBM advisory series. For IBM ELA renewal strategy, see IBM ELA Renewal Service. For IBM licensing assessments, see IBM Licensing Assessment Service. For common IBM licensing traps, see 10 Costly IBM Licensing Mistakes.

Get IBM Licensing Insights Delivered

Join enterprise IT leaders receiving our monthly advisory on IBM licensing, ELA renewal strategies, and cost optimisation.

Subscribe Free →

Professional Services — France  ·  IBM ELA Renewal Advisory  ·  7 min read

01 Client Background and Challenge

The client is a global professional services firm headquartered in France, providing consulting, legal advisory, and financial services to multinational corporations and government entities. The firm operates in more than 50 countries with approximately 45,000 employees, supported by a complex IT infrastructure spanning on-premises data centres, cloud environments, and virtualised platforms across Europe, the Americas, Asia-Pacific, and Africa.

The firm's IBM footprint had grown organically over more than a decade. It encompassed a wide range of IBM software products including WebSphere Application Server, MQ, Db2, Spectrum Protect (formerly Tivoli Storage Manager), SPSS, Cognos Analytics, and various IBM Cloud Pak components. These products were covered under an IBM Enterprise License Agreement (ELA) that was approaching its renewal date.

The firm's IT leadership recognised that the existing ELA had been renewed multiple times without a thorough review of actual usage, entitlements, or compliance position.

Challenge 1

No Centralised Licence Visibility

No centralised view of IBM licence entitlements versus actual deployments across the global estate. The firm's SAM team had visibility into European deployments but limited insight into installations across the Americas, Asia-Pacific, and Africa where regional IT teams operated with considerable autonomy.

Challenge 2

Unknown Compliance Exposure

Multiple IBM products had been deployed by regional IT teams without coordination with central licensing. This created an unknown compliance exposure that could surface during an IBM audit or ILMT review.

Challenge 3

Shelfware and Redundant Products

The existing ELA included products that were no longer actively used or had been replaced by cloud-native alternatives from Microsoft and AWS. But these products were still generating annual maintenance and subscription costs at each renewal.

Challenge 4

No Independent Benchmark Data

The firm had no independent benchmark data to assess whether IBM's renewal proposal represented fair market value. PVU counts, pricing tiers, and discount structures had never been compared against similarly sized enterprises.

The annual IBM spend was approximately €18.8 million, making it one of the firm's top five technology vendor relationships. The CIO recognised that a passive renewal, accepting IBM's proposal with modest negotiation, would lock the firm into another 3-year agreement based on an outdated technology landscape.

Redress Compliance Advisory Perspective

"This engagement is representative of a pattern we see frequently with IBM ELAs at global professional services firms. The ELA was originally structured a decade ago around a different IT landscape. Over successive renewals, products were added but rarely removed, usage shifted to cloud and SaaS alternatives, and regional deployments expanded without central oversight. By the time the firm engaged us, they were paying for an IBM estate that no longer reflected their actual technology needs."

02 Our Approach: Four-Phase Engagement

Redress Compliance deployed a structured four-phase engagement over 14 weeks, working closely with the firm's CIO office, IT procurement, and regional IT directors to deliver a complete ELA review, optimisation plan, and negotiation outcome.

Phase 1

Comprehensive Licensing Review (Weeks 1 to 4)

Full inventory of IBM software deployments across cloud, on-premises, and virtualised environments in all 50+ countries. Analysed ILMT data from every data centre and cloud instance. Cross-referenced deployment data with contractual entitlements from the existing ELA and all preceding agreements going back 12 years. Validated sub-capacity licensing eligibility for virtualised deployments running on VMware and IBM PowerVM. Identified undocumented deployments installed by regional IT teams outside the central procurement process.

The review covered 380+ servers across 14 data centres and co-location facilities, encompassing 12,000+ PVU entitlements across the full IBM middleware, database, and analytics stack.

We identified compliance gaps totalling approximately €2.1 million in unlicensed deployments. Primarily Db2 and WebSphere Application Server instances deployed in development and testing environments without proper entitlements, MQ installations in the Asia-Pacific region provisioned outside the ELA scope, and Cognos Analytics instances running on servers migrated to higher-capacity hardware without corresponding licence adjustments.

Phase 2

Licence Optimisation (Weeks 5 to 8)

With the complete deployment and entitlement picture established, we identified optimisation opportunities across four categories: redundant licences, overprovisioned licences, sub-capacity opportunities, and consolidation. 23 IBM products were deployed but no longer actively used or had been replaced by cloud-native alternatives. PVU allocations for WebSphere and Db2 exceeded actual usage by 35 to 40%. Sub-capacity corrections reduced the PVU requirement by approximately 4,200 PVUs.

Total annual savings identified: €3.2 million from licence optimisation plus €1.5 million from removing low-utilisation products. €4.7 million in combined annual savings.

Phase 3

Defining the Renewal ELA Scope (Weeks 9 to 11)

Non-critical solutions were removed entirely, reducing the ELA from 38 products to 22. A 42% reduction in product count. Each product removal was validated with the relevant business stakeholders. We built a forward-looking licensing roadmap accounting for planned cloud migrations, projected growth in remaining IBM products, and the transition from traditional PVU licensing to IBM Cloud Pak subscription models.

Phase 4

Negotiation Support (Weeks 12 to 14)

Direct negotiation support during discussions with IBM's account team, IBM Global Financing, and IBM's licensing specialists. The negotiation strategy leveraged optimised usage data, compliance gap remediation (removing IBM's audit leverage), and competitive alternatives from AWS and Microsoft Azure backed by proof-of-concept work the firm's infrastructure team had already completed.

03 Licence Optimisation: €4.7M in Annual Savings

The optimisation phase identified savings across four categories.

Redundant Licences

23 IBM products were deployed but no longer actively used or had been replaced by cloud-native alternatives. Cognos Analytics had been replaced by Microsoft Power BI in 6 of 8 regions. Spectrum Protect had been partially replaced by Veeam in European data centres. Several IBM Rational products were no longer in active use following a DevOps toolchain migration to Atlassian and GitLab. These products remained in the ELA, and the firm was paying annual maintenance on all of them.

Overprovisioned Licences

PVU allocations for WebSphere and Db2 exceeded actual usage by 35 to 40%. The overprovisioning originated from a virtualisation consolidation project three years earlier that reduced the number of physical servers without corresponding licence adjustments. The firm had continued paying for PVU entitlements sized for the pre-consolidation hardware.

Sub-Capacity Opportunities

Several virtualised environments running on VMware were eligible for sub-capacity licensing under IBM's ILMT rules but had been licensed at full physical capacity. In some cases, ILMT was deployed but not properly configured to capture sub-capacity data. In others, ILMT data existed but had never been used to optimise the PVU count. Correcting sub-capacity configurations reduced the PVU requirement by approximately 4,200 PVUs. A substantial reduction representing over €1.8 million in annual licence value.

Consolidation

Multiple overlapping IBM middleware products (WebSphere Application Server, IBM Integration Bus, API Connect, and DataPower Gateway) could be consolidated under IBM Cloud Pak for Integration. This reduced both licensing complexity and total cost while providing a modern, containerised middleware platform.

Total annual savings: €4.7 million. €3.2 million from licence optimisation plus €1.5 million from removing low-utilisation products.

Vendor Shield: IBM ELA Review

Approaching an IBM ELA renewal? Our independent review, optimisation, and negotiation support typically achieves 20 to 35% reductions in IBM ELA costs.

Learn More →

04 Negotiation and Outcome

The negotiation was conducted over three rounds spanning two weeks. IBM's initial position was to maintain the existing ELA scope with a modest discount. Our counter-position, supported by detailed deployment data and the competitive alternatives analysis, demonstrated that the firm's actual IBM requirement was 35% smaller than the existing ELA.

IBM's initial renewal proposal had been €19.5 million annually. A 3.7% increase over the existing ELA, reflecting IBM's standard escalation. With our optimisation data and competitive alternatives in hand, the negotiation produced a dramatically different outcome.

Concessions Secured

1

25% Pricing Reduction

Final ELA structured at €14.1 million annually. Down from €18.8 million in the previous agreement and €19.5 million in IBM's opening proposal.

2

Annual True-Down Rights

Licensing flexibility allowing the firm to reduce PVU commitments annually if usage decreased. A critical provision for a firm actively migrating workloads to cloud alternatives.

3

Sub-Capacity Guarantees

Contractual confirmation of sub-capacity eligibility for all virtualised environments. Removing ambiguity that IBM could exploit during future compliance reviews.

4

Growth Protection Clauses

New product additions at pre-negotiated discount rates. Plus extended payment terms through IBM Global Financing that improved the firm's cash flow position.

Before and After

MetricBefore EngagementAfter EngagementImpact
Annual IBM ELA cost€18.8M€14.1M25% reduction (€4.7M saved annually)
Compliance status€2.1M in unlicensed deploymentsFully compliantAudit risk eliminated
Products in ELA38 products22 products42% portfolio reduction
PVU entitlements12,000+ PVUs7,800 PVUs35% reduction through optimisation
Licence visibilityNo centralised viewComplete global inventoryOngoing governance capability
Contract flexibilityFixed 3-year commitmentAnnual true-down rightsAbility to reduce commitment annually
Client Testimonial — CIO, French Global Professional Services Company

"Redress Compliance's expertise in IBM ELA reviews was instrumental in delivering a cost-effective and strategically aligned agreement. Their guidance ensured compliance, optimised our licensing, and positioned us for future success. Their support during negotiations was invaluable. They understood IBM's tactics and countered every pressure point with data and alternatives."

05 Key Lessons for Enterprises with IBM ELAs

This engagement illustrates several principles that apply broadly to any enterprise managing an IBM Enterprise License Agreement. The patterns we identified are common across industries and geographies.

Lesson 1

Never Renew an IBM ELA Without an Independent Review

IBM's renewal proposals are based on the existing ELA scope, not on actual usage. Without an independent review that maps entitlements to deployments, enterprises routinely renew licences they no longer need. In this case, 16 of 38 products in the ELA were candidates for removal. The independent review paid for itself more than 50 times over in annual savings. See our IBM ELA Renewal Service.

Lesson 2

Compliance Gaps Give IBM Negotiation Leverage. Fix Them First.

The €2.1M in compliance gaps we identified would have given IBM significant leverage in renewal negotiations. IBM could have used audit findings to pressure the firm into a larger, more expensive ELA. By remediating compliance before entering negotiations, we removed IBM's leverage entirely and shifted the dynamic from defensive (resolving non-compliance) to offensive (optimising costs). See our IBM Audit Defense Service.

Lesson 3

Sub-Capacity Licensing Is Frequently Misconfigured

IBM's sub-capacity licensing rules allow enterprises to license only the PVUs allocated to virtual machines rather than the full physical host, but only if ILMT is properly deployed and configured. In this engagement, several environments were eligible for sub-capacity but had not been properly configured, resulting in 4,200 PVUs of unnecessary licensing. Correcting sub-capacity configurations is one of the highest-ROI optimisation activities for IBM customers running virtualised environments. See The Hidden Cost of IULA.

Frequently Asked Questions

Through a combination of licence optimisation (removing 16 redundant products, right-sizing overprovisioned PVU allocations, correcting sub-capacity configurations) and strategic negotiation leveraging competitive alternatives and remediated compliance gaps. The €4.7M annual savings represented a 25% reduction from the previous agreement.

An IBM ELA is a multi-year licensing agreement that bundles multiple IBM software products under a single contract with volume-based pricing. ELAs typically run for 3 years and include maintenance, support, and defined PVU entitlements. They are IBM's preferred commercial structure for large enterprise customers.

IBM's renewal proposals are based on the existing ELA scope, not on actual usage. Without an independent review, enterprises routinely renew licences for products they no longer use and pay for PVU entitlements that exceed their actual deployment. Independent reviews typically identify 20 to 40% in savings opportunities.

PVU (Processor Value Unit) is IBM's primary licence metric for middleware, database, and application server products. The PVU count is calculated based on the processor type and core count of the servers running IBM software. Sub-capacity licensing allows customers to pay only for the PVUs allocated to virtual machines rather than the full physical host, but requires ILMT to be deployed and properly configured.

Sub-capacity licensing allows enterprises to license only the processor cores allocated to the virtual machines running IBM software, rather than the full physical server capacity. This can reduce the PVU requirement by 50 to 80% in heavily virtualised environments. However, it requires IBM License Metric Tool (ILMT) to be properly deployed and configured across all virtualised environments.

FF

Fredrik Filipsson

Co-Founder, Redress Compliance

Fredrik Filipsson brings over 20 years of enterprise software licensing expertise, having worked directly for IBM, SAP, and Oracle before co-founding Redress Compliance. With deep experience in IBM licensing, ELA negotiations, and audit defence, Fredrik leads the firm's IBM advisory practice from offices in Fort Lauderdale, Dublin, and Dubai.

Approaching an IBM ELA Renewal?

Redress Compliance provides independent IBM ELA review, optimisation, and negotiation support. Our clients typically achieve 20 to 35% reductions in IBM ELA costs.

IBM ELA Renewal Service →